Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Guillain-Barré syndrome: expanding the concept of molecular mimicry

Trends in Immunology(2022)10.1016/j.it.2022.02.003Source: DataRank Database

Guillain-Barré syndrome: expanding the concept of molecular mimicry is a research paper published in Trends in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 100 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access100 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 9.86)OA: greenTopics (39)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Ruth Huizinga ORCID,Geert‐Jan Boons ORCID,Bart C. Jacobs ORCID,Jon D. Laman ORCID

Live enrichment

PubMed:35256276 PMC:PMC9016725 OpenAlex:https://openalex.org/W4214951143

NIGMS NIH HHS

Grant: U01 GM120408

National Institutes of Health

Grant: 3U01GM120408-03S1

Streamlining the chemoenzymatic synthesis of asymmetrical glycans of biological importance

FWCI

9.86

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: other-oa

repositoryhttps://pure.eur.nl/en/publications/3c3c9ec4-cff2-4b9d-9ebe-9d7505b60158

publisherhttps://api.elsevier.com/content/article/PII:S147149062200028X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S147149062200028X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.it.2022.02.003

Fields of Study

Peripheral Neuropathies and DisordersMonoclonal and Polyclonal Antibodies ResearchAutoimmune Neurological Disorders and Treatments0301 basic medicine03 medical and health sciences0302 clinical medicineAntibody FormationAutoantibodiesGangliosidesGuillain-Barre SyndromeHumansImmunoglobulin GMolecular Mimicry

MeSH Terms

Antibody FormationAutoantibodiesGangliosidesHumansImmunoglobulin GMolecular MimicryGuillain-Barre Syndrome

Keywords

Molecular mimicryGuillain-Barre syndromeImmunologyAntibodyEpitopeBiologyImmune systemDiseaseMedicinePathologySDG 3 - Good Health and Well-beingGangliosidesImmunoglobulin GTaverneAntibody FormationImmunology and AllergyHumansGuillain-Barre Syndrome/etiologyAutoantibodies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Industry, innovation and infrastructure

Additional file 1 of P2X7 receptor antagonists modulate experimental autoimmune neuritis via regulation of NLRP3 inflammasome activation and Th17 and Th1 cell differentiation

10.6084/m9.figshare.25478818.v1figshare

Additional file 1 of P2X7 receptor antagonists modulate experimental autoimmune neuritis via regulation of NLRP3 inflammasome activation and Th17 and Th1 cell differentiation

10.6084/m9.figshare.25478818figshare

Additional file 2 of P2X7 receptor antagonists modulate experimental autoimmune neuritis via regulation of NLRP3 inflammasome activation and Th17 and Th1 cell differentiation

10.6084/m9.figshare.25479115.v1figshare

Additional file 2 of P2X7 receptor antagonists modulate experimental autoimmune neuritis via regulation of NLRP3 inflammasome activation and Th17 and Th1 cell differentiation

10.6084/m9.figshare.25479115figshare